Close
CDMO Safety Testing 2026
Novotech

KLN Named Exclusive Distributor for Siemens Healthineers Point-of-Care Testing Solutions in Hong Kong

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

Lilly Signs $1.26bn Sonefpeglutide Licensing Deal with Hanmi

Eli Lilly and Company and Hanmi Pharm have officially...

Pharmacogenomics in 2026: From Research Concept to Clinical Workflow

Pharmacogenomics has moved well beyond the research phase. In...

Pfizer and Innovent Finalize $10.5 Billion Global Oncology Agreement

The Pfizer Innovent Cancer Deal has been finalized, establishing...
- Advertisement -

KLN Logistics Group Limited announced a strategic partnership between its healthcare subsidiary, KLN Medical Limited (โ€˜KLN Medicalโ€™), and global medical technology leader Siemens Healthineers AG (Stock Code SHL.DE). KLN Medical will serve as the exclusive distributor for Siemens Healthineersโ€™ Point-of-Care Testing products in Hong Kong.

This partnership marks a major milestone for KLN Medical as it expands in life sciences sector. KLN Medical will provide end-to-end agency and distribution services for Siemens Healthineersโ€™ diagnostic portfolio, with a strong focus on professional sales and marketing outreach to hospitals and healthcare providers. Its in-house engineering team will deliver maintenance and repair services to ensure optimal device performance and minimise service disruptions. These capabilities are supported by GDP-compliant logistics, warehousing, and inventory management that uphold the highest standards of medical supply chain excellence.

KLN Medical will distribute these solutions across major hospitals, laboratories, clinics, rehabilitation outlets, and healthcare providers throughout Hong Kong, ensuring Siemens Healthineersโ€™ technologies are accessible and fully supported throughout their lifecycle to maximise clinical value and reliability.

Samuel Lau, Managing Director – Integrated Logistics of KLN, said, โ€œWe are honored to collaborate with Siemens Healthineers, a global leader in diagnostic innovation. This partnership reflects KLNโ€™s commitment to resilient, patient-centric care by ensuring timely access to reliable diagnostics and full-spectrum support.โ€

In addition to logistics and technical services, KLN Medical will support local marketing, product training, and clinical outreach to enhance engagement with frontline healthcare providers.

Mike Yuen, Head of Hong Kong of Siemens Healthineers, said, โ€œKLN Medicalโ€™s strengths in commercial and technical support make them an ideal partner for our expansion in Hong Kong. Together, we will ensure our innovations reach patients and clinicians with excellence and efficiency.โ€

Siemens Healthineersโ€™ diagnostic solutions are widely used across Hong Kongโ€™s healthcare system, particularly in operating theatres, ICUs, emergency departments, and cardiology units. For example, Queen Mary Hospitalโ€™s nationally certified Chest Pain Center uses Siemens Healthineers’ systems to reduce time-to-treatment for acute chest pain, demonstrating the clinical impact of rapid diagnostics.

This collaboration reinforces KLN Medicalโ€™s role as a key enabler in Hong Kongโ€™s medical diagnostics landscape and supports its long-term vision of a more efficient, responsive, and patient-centric healthcare system.

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast โ€“ stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Latest stories

Related stories

Lilly Signs $1.26bn Sonefpeglutide Licensing Deal with Hanmi

Eli Lilly and Company and Hanmi Pharm have officially...

Pharmacogenomics in 2026: From Research Concept to Clinical Workflow

Pharmacogenomics has moved well beyond the research phase. In...

Pfizer and Innovent Finalize $10.5 Billion Global Oncology Agreement

The Pfizer Innovent Cancer Deal has been finalized, establishing...

Nestlรฉ and IdB Partner to Bring rCDI Preventive Therapy to Europe

Nestlรฉ Health Science and IdB Holding have officially announced...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป